![Celecoxib loses its anti‐inflammatory efficacy at high doses through activation of NF‐κB - Niederberger - 2001 - The FASEB Journal - Wiley Online Library Celecoxib loses its anti‐inflammatory efficacy at high doses through activation of NF‐κB - Niederberger - 2001 - The FASEB Journal - Wiley Online Library](https://faseb.onlinelibrary.wiley.com/cms/asset/d99ca0ed-fe46-42b8-be0c-cdbf63ce84f0/fsb2fj000716fje-fig-0003-m.jpg)
Celecoxib loses its anti‐inflammatory efficacy at high doses through activation of NF‐κB - Niederberger - 2001 - The FASEB Journal - Wiley Online Library
![Celecoxib | CAS:169590-42-5 | Selective cyclooxygenase-2 (COX-2) inhibitor | High Purity | Manufacturer BioCrick Celecoxib | CAS:169590-42-5 | Selective cyclooxygenase-2 (COX-2) inhibitor | High Purity | Manufacturer BioCrick](https://www.biocrick.com/media/images/struct/BCC1099.png)
Celecoxib | CAS:169590-42-5 | Selective cyclooxygenase-2 (COX-2) inhibitor | High Purity | Manufacturer BioCrick
![Restoration of tumor suppressor p53 by differentially regulating pro- and anti-p53 networks in HPV-18-infected cervical cancer cells | Oncogene Restoration of tumor suppressor p53 by differentially regulating pro- and anti-p53 networks in HPV-18-infected cervical cancer cells | Oncogene](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fonc.2011.234/MediaObjects/41388_2012_Article_BFonc2011234_Fig1_HTML.jpg)
Restoration of tumor suppressor p53 by differentially regulating pro- and anti-p53 networks in HPV-18-infected cervical cancer cells | Oncogene
![Celecoxib | CAS:169590-42-5 | Selective cyclooxygenase-2 (COX-2) inhibitor | High Purity | Manufacturer BioCrick Celecoxib | CAS:169590-42-5 | Selective cyclooxygenase-2 (COX-2) inhibitor | High Purity | Manufacturer BioCrick](https://www.biocrick.com/media/images/struct3D/BCC1099.png)
Celecoxib | CAS:169590-42-5 | Selective cyclooxygenase-2 (COX-2) inhibitor | High Purity | Manufacturer BioCrick
![Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy | Molecular Cancer | Full Text Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy | Molecular Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1476-4598-8-66/MediaObjects/12943_2009_Article_451_Fig1_HTML.jpg)
Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy | Molecular Cancer | Full Text
![Diclofenac potentiates the antitumor effect of cisplatin in a xenograft mouse model transplanted with cisplatin-resistant cells without enhancing cisplatin-induced nephrotoxicity - ScienceDirect Diclofenac potentiates the antitumor effect of cisplatin in a xenograft mouse model transplanted with cisplatin-resistant cells without enhancing cisplatin-induced nephrotoxicity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1347436721000380-gr2.jpg)
Diclofenac potentiates the antitumor effect of cisplatin in a xenograft mouse model transplanted with cisplatin-resistant cells without enhancing cisplatin-induced nephrotoxicity - ScienceDirect
![Celecoxib loses its anti‐inflammatory efficacy at high doses through activation of NF‐κB - Niederberger - 2001 - The FASEB Journal - Wiley Online Library Celecoxib loses its anti‐inflammatory efficacy at high doses through activation of NF‐κB - Niederberger - 2001 - The FASEB Journal - Wiley Online Library](https://faseb.onlinelibrary.wiley.com/cms/asset/3b787d22-d470-4a61-bb4d-e472eac9a671/fsb2fj000716fje-fig-0004-m.jpg)